Sanjivani Paranteral Ltd's Stock Reaches All-Time High, Outperforms Sector by 0.68%

Aug 27 2024 10:00 AM IST
share
Share Via
Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on August 27th, 2024. The stock has been outperforming its sector by 0.68% and has been gaining for the past two days, rising by 2.25%. It is currently trading higher than its moving averages and has shown a growth of 233.71% in the past year, showcasing its strong performance in the market. However, MarketsMojo has given a 'Sell' call for the stock, indicating caution for investors.
Sanjivani Paranteral Ltd's Stock Reaches All-Time High, Outperforms Sector by 0.68%
Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high on August 27th, 2024. The stock has been performing well in the market, outperforming its sector by 0.68%. In fact, it has been gaining for the past two days and has risen by 2.25% during this period. The company's stock is currently trading at a price that is 1.53% away from its 52-week high of Rs 298. This indicates a strong performance by the company in the market. Additionally, Sanjivani Paranteral Ltd is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which further reflects its positive momentum. In comparison to the overall market performance, Sanjivani Paranteral Ltd has shown an impressive growth of 233.71% in the past year, while the Sensex has only grown by 26.08%. This showcases the company's strong performance and potential for growth in the pharmaceutical industry. However, it is important to note that MarketsMOJO has given a 'Sell' call for Sanjivani Paranteral Ltd's stock. This indicates that investors should carefully consider their options before making any investment decisions. Overall, Sanjivani Paranteral Ltd's recent surge in stock price and its strong performance in the market make it a company to watch out for in the pharmaceutical industry. However, investors should conduct their own research and make informed decisions before investing in the company's stock.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sanjivani Paranteral Ltd is Rated Sell
Feb 06 2026 10:10 AM IST
share
Share Via
When is the next results date for Sanjivani Paranteral Ltd?
Feb 05 2026 11:16 PM IST
share
Share Via
Sanjivani Paranteral Ltd is Rated Sell
Jan 26 2026 10:10 AM IST
share
Share Via
Sanjivani Paranteral Ltd is Rated Sell
Jan 15 2026 10:10 AM IST
share
Share Via